Radiation Applications

Radioisotopes / US Company Announces First Commercial Sales Of Lutetium-77

By David Dalton
11 November 2020

US Company Announces First Commercial Sales Of Lutetium-77
A computer-generated image of the planned radioisotope facility. Courtesy Shine.
Wisconsin-based Shine Medical Technologies, a nuclear technology company focused on becoming a leading producer of medical isotopes, announced that its therapeutics division has made its first commercial sales of lutetium-177 to multiple customers.

Want to know more?
Sign up.

Pen Use this content

Tags


Related